XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments and Fair Value | 9 Months Ended
--- | ---
Sep. 30, 2025
Financial Instruments and Fair Value [Abstract] |
Financial Instruments and Fair Value | Financial Instruments and Fair Value. The following table provides information about assets and liabilities not carried at fair value and excludes asset and liabilities without readily determinable fair value.
|  | September 30, 2025 |  | December 31, 2024
|  | Carrying amount |  | Estimated fair value |  | Carrying amount (net) |  | Estimated fair value
Liabilities | Borrowings (Note 9) | $ | 967.8 |  |  | $ | 1,021.2 |  |  | $ | 966.0 |  |  | $ | 987.4 |
Assets and liabilities that are reflected in the accompanying condensed consolidated financial statements at fair value are not included in the above disclosures; such items include short- and long-term investment, deferred compensation and derivative financial instruments. Substantially all of these assets are considered to be Level 1 and substantially all of the Company's liabilities' fair value are considered Level 2, with the exception of derivative instruments which are considered Level 2 for both assets and liabilities. Derivatives and Hedging. The Company is exposed to various market risks such as changes in foreign currency rates. The Company uses derivatives to manage risks related to changes in foreign currency exchange rates arising from international trade, foreign currency monetary asset and liability balances and investments in foreign subsidiaries. The Company's policy requires that derivatives are used solely for managing risks and not for speculative purposes. The Company manages counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, by limiting the amount of credit exposure to individual counterparties, and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Net Investment Hedges. The Company designates foreign currency forwards to hedge a portion of foreign investments in its EUR and BRL denominated operations. As of September 30, 2025, this included 16 EUR-USD and 9 BRL-USD foreign currency forward instruments. The Company uses the forward method to assess hedge effectiveness for its net investment hedges. Gains and losses on these instruments are initially recognized in our Statement of Other Comprehensive Income (Loss) and are reclassified out of AOCI into gain or loss on sale of investment when the hedged net investment is either sold or substantially liquidated. Cash flows from the net investment hedges are classified as Certain other assets and liabilities on the Statement of Cash Flows. Non-Designated Hedges. The Company uses non-designated foreign exchange forward contracts with maturities of up to 12 months to mitigate the impact of currency fluctuations on foreign currency asset and liability balances. Forward-based gains/losses are classified as foreign exchange gain (loss), net on the Statement of Earnings. No foreign exchange forward contracts were utilized during 2024. Cash flows from the foreign exchange forward contracts are classified as Certain other assets and liabilities on the Statement of Cash Flows. Fair Value of Derivatives. The following table presents the fair value of our derivative instruments and identifies the balance sheet line items in which these amounts are included. All fair values are presented on a gross basis, consistent with the Company's policy to not elect to net derivative assets and liabilities that are subject to master netting agreements:
| September 30, 2025 |  |
| Gross notional |  | Other current assets |  | Other current liabilities |  |  |  |  |  |
Designated forward currency exchange contracts 1 | $ | 366.1 |  |  | $ | 2.7 |  |  | $ | (5.1) |  |  |  |  |  |  |
Non-Designated forward exchange contracts 2 | $ | 469.2 |  |  | 5.3 |  | (3.9) |  |  |  |  |  |  |
Net derivatives recognized in statement of financial position |  |  | $ | 8.0 |  |  | $ | (9.0) |  |  |  |  |  |  |
1 Gains (losses) in our Other comprehensive Income (loss) driven by net investment hedges was $6.8 for the three and nine months ended September 30, 2025, respectively. 2 Gains (losses) in our Statement of Earnings (loss) driven by hedges of foreign exchange fluctuation was $5.5 for the three and nine months ended September 30, 2025, respectively. These amounts are offset by the remeasurement of the underlying exposure through foreign exchange gain or loss, net on the Statement of Earnings.

X
- Definition Financial Instruments and Fair Value + References No definition available. + Details
Name: | dbd_FinancialInstrumentsAndFairValueAbstract
Namespace Prefix: | dbd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration